Wayfair (W) engages in the e-commerce business in the United States. It offers approximately seven million products for the home under various brands. The company offers a selection of furniture, décor, decorative accent, houseware, seasonal décor, and other home goods…
NewLonKong
NewLonKong: New York, London, Hong Kong, For Individual Investors
Category: Growth
Landmark Infrastructure Partners LP (LMRK)
Landmark Infrastructure Partners LP (LMRK) is engaged in acquiring, owning and managing a portfolio of real property interests. The Company leases its properties to companies in the wireless communication, outdoor advertising and renewable power generation industries.
Apollo Commercial Real Estate Finance, Inc. (ARI)
Apollo Commercial Real Estate Finance, Inc. (ARI) is a real estate investment trust (REIT). The Company primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, commercial mortgage-backed securities (CMBS) and other commercial real estate-related debt…
Brookfield Renewable Partners L.P. (BEP)
Brookfield Renewable Partners L.P. (BEP) is a pure-play renewable business. It has 260 power-generating facilities totaling US$25 billion of assets with about 10,700 MW of installed capacity. Its portfolio is 88% hydroelectric generation, and it is complemented by 11% of…
RXP (RXP.AX)
RXP (RXP.AX) is a (digital) technology services company in Australia with strong growth so far.
China Distance Education (DL)
China Distance Education (DL) is the leading long-distance education network company in China. 1 ADR = 4 shares
VIPShop (VIPS)
VIPShop (VIPS) is an speciality online shop in China. 1 ADR = 5 ordinary shares.
YY (YY)
YY (YY) is China’s leading live broadcasting company with good cash flow and net income.
Tagged with: YY
Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals (REGN) is a rising star. Its sales have been growing strongly every year in the past and will do so in the future. Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for the treatment of…
Celgene (CELG)
Celgene Corporation (CELG) discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma
Top
Recent Comments